|
Randomized phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer: Final analysis of AGO DESKTOP III/ENGOT-ov20. |
| |
|
Consulting or Advisory Role - AstraZeneca; BioCad; Clovis Oncology; Genmab; Ingress Health; Roche/Genentech; Tesaro; TLC Biopharmaceuticals |
| |
|
Honoraria - AstraZeneca; Bayer; Clovis Oncology; Eisai; GlaxoSmithKline; Johnson & Johnson; MSD Oncology; Olympus Medical Systems; Pfizer; PharmaMar; Tesaro; Teva |
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Johnson & Johnson; Lilly; Merck; MSD Oncology; Novocure; Pfizer; PharmaMar; Tesaro |
Research Funding - AstraZeneca (Inst); Bayer (Inst); Clovis Oncology (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Tesaro (Inst) |
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; MSD Oncology; Olympus; PharmaMar; Roche Pharma AG; Tesaro; Tesaro |
| |
|
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Carrick Therapeutics (Inst); Clovis Oncology (Inst); Debiopharm Group (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Immunogen (Inst); Medical University of Vienna (Inst); Millennium (Inst); MSD Belgium (Inst); Octimet (Inst); Oncoinvent (Inst); PharmaMar (Inst); Roche (Inst); Roche (Inst); Sotio (Inst); Tesaro (Inst) |
Research Funding - Amgen (Inst); Genmab (Inst); Oncoinvent (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - Amgen; AstraZeneca; MSD/Merck; Roche; Tesaro |
| |
|
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline/Tesaro; Olympus; RanD Biotech |
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar; Roche Pharma AG |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - AstraZeneca; Roche; Tesaro |
| |
|
Consulting or Advisory Role - AstraZeneca; Roche |
Travel, Accommodations, Expenses - Roche |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Tesaro |
Travel, Accommodations, Expenses - AstraZeneca; Tesaro |
| |
|
No Relationships to Disclose |
| |
Elisabeth Avall-Lundqvist |
|
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Genmab; Tesaro |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Abex; KCI; Medtronic |
| |
|
Consulting or Advisory Role - Tesaro/GSK |
Travel, Accommodations, Expenses - Roche |
| |
|
Travel, Accommodations, Expenses - AstraZeneca; Johnson & Johnson |
| |
|
Honoraria - Amgen; AstraZeneca; GlaxoSmithKline; Novartis; PharmaMar; Roche; Tesaro |
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar; Roche; Tesaro |
| |
|
Honoraria - AstraZeneca; Clovis Oncology; Lilly; MSD Oncology; Roche; Sotio; Stryker; Tesaro; Zai Lab |
Consulting or Advisory Role - AstraZeneca; Merck; Roche; Tesaro |
Research Funding - AstraZeneca (Inst); Genmab (Inst); Roche (Inst); Tesaro (Inst) |